Cefatrizine

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 329202

CAS#: 51627-14-6

Description: Cefatrizine, also known as BL-S-640 and S-640P, is a eukaryotic elongation factor-2 kinase inhibitor with an anti-proliferative activity toward breast cancer cells. Eukaryotic elongation factor-2 kinase, a unique calcium/calmodulin-dependent protein kinase, is well known to regulate apoptosis, autophagy and ER stress in many types of human cancers.

Chemical Structure

img
Cefatrizine
CAS# 51627-14-6
Instruction

Theoretical Analysis

MedKoo Cat#: 329202
Name: Cefatrizine
CAS#: 51627-14-6
Chemical Formula: C18H18N6O5S2
Exact Mass: 462.08
Molecular Weight: 462.499
Elemental Analysis: C, 46.75; H, 3.92; N, 18.17; O, 17.30; S, 13.86

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Cefatrizine; BL-S-640; BL S 640; BLS640; Cephatriazine; S 640P; S-640P; S640P

IUPAC/Chemical Name: (6R,7R)-3-(((1H-1,2,3-triazol-4-yl)thio)methyl)-7-(2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

InChi Key: UOCJDOLVGGIYIQ-QQGYXAEISA-N

InChi Code: InChI=1S/C18H18N6O5S2/c19-12(8-1-3-10(25)4-2-8)15(26)21-13-16(27)24-14(18(28)29)9(7-31-17(13)24)6-30-11-5-20-23-22-11/h1-5,12-13,17,25H,6-7,19H2,(H,21,26)(H,28,29)(H,20,22,23)/t12?,13-,17-/m1/s1

SMILES Code: O=C(C(N12)=C(CSC3=CNN=N3)CS[C@]2([H])[C@H](NC(C(N)C4=CC=C(O)C=C4)=O)C1=O)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 462.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Pan J, Wang L, Li D, Ye L. [Synthesis of cefatrizine by recombinant alpha-amino acid ester hydrolase]. Sheng Wu Gong Cheng Xue Bao. 2013 Apr;29(4):501-9. Chinese. PubMed PMID: 23894823.

2: Papantoniou N, Ismailos G, Daskalakis G, Karabinas C, Mesogitis S, Papapanagiotou A, Antsaklis A. Pharmacokinetics of oral cefatrizine in pregnant and non-pregnant women with reference to fetal distribution. Fetal Diagn Ther. 2007;22(2):100-6. PubMed PMID: 17135753.

3: Choi HG, Jun HW, Kim DD, Sah H, Yoo BK, Yong CS. Simultaneous determination of cefatrizine and clavulanic acid in dog plasma by HPLC. J Pharm Biomed Anal. 2004 Apr 1;35(1):221-31. PubMed PMID: 15030898.

4: Sultana N, Arayne MS. In vitro activity of cefadroxil, cephalexin, cefatrizine and cefpirome in presence of essential and trace elements. Pak J Pharm Sci. 2007 Oct;20(4):305-10. PubMed PMID: 17604254.

5: Yao Z, Li J, Liu Z, Zheng L, Fan N, Zhang Y, Jia N, Lv J, Liu N, Zhu X, Du J, Lv C, Xie F, Liu Y, Wang X, Fei Z, Gao C. Integrative bioinformatics and proteomics-based discovery of an eEF2K inhibitor (cefatrizine) with ER stress modulation in breast cancer cells. Mol Biosyst. 2016 Mar;12(3):729-36. doi: 10.1039/c5mb00848d. PubMed PMID: 26776155.

6: Matsuda K, Yuasa H, Watanabe J. Dose dependency in the gastrointestinal absorption of cefatrizine: correlation between in vivo and in situ. Biol Pharm Bull. 1998 Jun;21(6):604-9. PubMed PMID: 9657046.

7: Yu LX, Amidon GL. Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data. Eur J Pharm Biopharm. 1998 Mar;45(2):199-203. PubMed PMID: 9704917.

8: Brambilla C, Benhamou D, Guérin JC, Kelkel E, Muir JF, Prud'homme A, Taytard A, Fauche A. [Comparative trial of the clinical efficacy and tolerance of cefatrizine (Cefaperos) and cefpodoxime proxetil (Orelox) in superinfections of chronic obstructive bronchopneumopathies in adults in urban practice]. Pathol Biol (Paris). 1995 Nov;43(9):815-24. French. PubMed PMID: 8746104.

9: Couet W, Fauvel JP, Laville M, Pozet N, Fourtillan JB. Pharmacokinetics of oral cefatrizine in patients with impaired renal function. Int J Clin Pharmacol Ther Toxicol. 1991 Jun;29(6):213-7. PubMed PMID: 1869342.

10: Couet W, Reigner BG, Lefebvre MA, Bizouard J, Fourtillan JB. [Pharmacokinetics of cefatrizine administered in repeated doses]. Pathol Biol (Paris). 1988 May;36(5):513-6. French. PubMed PMID: 3043350.

11: Neu HC, Fu KP. Cefatrizine activity compared with that of other cephalosporins. Antimicrob Agents Chemother. 1979 Feb;15(2):209-12. PubMed PMID: 426514; PubMed Central PMCID: PMC352634.

12: Pfeffer M, Gaver RC, Ximenez J. Human intravenous pharmacokinetics and absolute oral bioavailability of cefatrizine. Antimicrob Agents Chemother. 1983 Dec;24(6):915-20. PubMed PMID: 6660858; PubMed Central PMCID: PMC185407.

13: Mastrandrea V, Ripa S, La Rosa F, Ghezzi A. Pharmacokinetics of cefatrizine after oral administration in human volunteers. Int J Clin Pharmacol Res. 1985;5(5):319-23. PubMed PMID: 4066082.

14: Reigner BG, Couet W, Guedes JP, Fourtillan JB, Tozer TN. Saturable rate of cefatrizine absorption after oral administration to humans. J Pharmacokinet Biopharm. 1990 Feb;18(1):17-34. PubMed PMID: 2329468.

15: Cremonesi G, Tarantino V, Stura M, Ciampini M. Comparison of cefatrizine and erythromycin for pediatric ear, nose, and throat infections. Clin Ther. 1987;9(3):263-6. PubMed PMID: 3300988.